p16CDKN2A expression during rat tongue carcinogenesis induced by 4-Nitroquinoline-1-oxide

Oral Oncology

Volumn 45, Issue 7, 2009, Pages 640-644

  Hong, Yun ^a   Li, Chunyang ^a   Xia, Juan ^a   Rhodus, Nelson L ^b   Cheng, Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Institute for Molecular Virology   (United States)

Author keywords

4 Nitroquinoline 1 oxide; Oral squamous cell carcinoma; p16CDKN2A; Posttranscriptional mechanism; Rat; Tongue carcinoma

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; INVASIVE CARCINOMA; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOGENESIS; TONGUE CARCINOMA; TUMOR SUPPRESSOR GENE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE SILENCING; GENES, P16; MALE; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; TONGUE NEOPLASMS;

EID: 67449090699     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.06.007     Document Type: Article

References (20)

1. Ai L., Stephenson K.K., Ling W., Zuo C., Mukunyadzi P., Suen J.Y., et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 16 (2003) 944-950
2. Rocco J.W., and Sidransky D. p16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264 (2001) 42-55
3. Vairaktaris E., Yapijakis C., Psyrri A., Spyridonidou S., Yannopoulos A., Lazaris A., et al. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res 27 (2007) 979-984
4. Vered M., Yarom N., and Dayan D. 4NQO oral carcinogenesis: animal models, molecular markers and future expectations. Oral Oncol 41 (2005) 337-339
5. Hong Y., Yang L.L., Li C.Y., Xia H.B., Rhodus N.L., and Cheng B. Frequent mutation of p16CDKN2A Exon 1 during rat tongue carcinogenesis induced by 4-Nitroquinoline-1-Oxide. Mol Carcinogen 46 (2007) 85-90
6. INK4a in primary rat lung tumors. Mol Cell Biol 17 (1997) 1366-1374
7. Sharangpani G.M., Joshi A.S., Porter K., Deshpande A.S., Keyhani S., Naik G.A., et al. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J Microsc 226 (2007) 244-255
8. Kim W.Y., and Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 127 (2006) 265-275
9. Sartor M., Steingrimsdottir H., Elamin F., Gaken J., Warnakulasuriya S., Partridge M., et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Br J Cancer 80 (1999) 79-86
10. Pande P., Mathur M., Shukla N.K., and Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 34 (1998) 396-403
11. Papadimitrakopoulou V., Izzo J., Lippman S.M., Lee J.S., Fan Y.H., Clayman G., et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 14 (1997) 1799-1803
12. Fu Y., Deng W., Kawarada Y., Kawagoe M., Ma Y.Z., Li X., et al. Mutation and expression of the p53 gene during chemical hepatocarcinogenesis in F344 rats. Biochim Biophys Acta 1628 (2003) 40-49
13. Rosas S.L., Koch W., da Costa Carvalho M.G., Wu L., Califano J., Westra W., et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA- methyltransferase, and Death-associated Protein Kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61 (2001) 939-942
14. Okami K., Reed A.L., Cairns P., Koch W.M., Westra W.H., Wehage S., et al. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene 18 (1999) 3541-3545
15. Kim H.S., Chung W.B., Hong S.H., Kim J.A., Na S.Y., Jang H.J., et al. Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma. Mol Cells 10 (2000) 557-565
16. Gawa T., Sugihara H., Tani T., and Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 62 (2002) 4938-4944
17. INK4b in undifferentiated mouse skin tumors. Cancer Res 55 (1995) 5168-5172
18. Hui A.M., Sakamoto M., Kanai Y., Ino Y., Gotoh M., Yokota J., et al. Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology 24 (1996) 575-579
19. Saegusa M., Machida B.D., and Okayasu I. Possible associations among expression of p14(ARF), p16(INK4a), p21(WAF1/CIP1), p27(KIP1), and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer 92 (2001) 1177-1189
20. Han X.L., Wu F.G., Zhang Z.Y., and Tong T.J. Posttranscriptional induction of p21Waf1 mediated by ectopic p16INK4 in human diploid fibroblast. Chin Med J (Engl) 120 (2007) 405-409